10 Results for "

anti-TNF-α

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "anti-TNF-α" in MCE Product Catalog:

30
30 Publications Verification
Cat. No.: HY-P9970
CAS No.: 170277-31-3
Synonyms: Avakine; CT-P13; SB2; TA-650
Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research .
The component ratio of this product is Active ingredient : Excipients = 9 : 47.
loading...
    loading...
30
30 Publications Verification
Cat. No.: HY-P9970A
Synonyms: Avakine (anti-TNF-α); CT-P13 (anti-TNF-α)
Infliximab (Anti-TNF-α) (Avakine (Anti-TNF-α)) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab (Anti-TNF-α) prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab (Anti-TNF-α) has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research .
loading...
    loading...
Cat. No.: HY-126360
CAS No.: 15646-46-5
Purity:  ≥98.0%
Research Areas:  

Inflammation/Immunology

Oxazolone is a haptenizing agent that induces acute or chronic inflammation of the large intestine and is used to construct models of colitis. Oxazolone can cause Th1/Th2-dependent colitis with weight loss and diarrhea. Oxazolone-induced inflammation can be mitigated by neutralizing anti-IL-4 or anti-TNF-α antibodies or decoy IL-13R2-α-FC proteins .
loading...
    loading...
Cat. No.: HY-P99796
CAS No.: 1167985-17-2
Synonyms: ATN-103; PF-5230896

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .
loading...
    loading...
Cat. No.: HY-P99704
CAS No.: 1688648-13-6
Synonyms: OCS-02

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation .
loading...
    loading...
Cat. No.: HY-P99775
CAS No.: 945781-29-3
Synonyms: ART621; CEP-37247; PN0621

Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

Placulumab (ART621) is an anti-TNF α monoclonal antibody. Placulumab has anti-inflammatory activity and has potential applications in inflammatory diseases such as arthritis .
loading...
    loading...
Cat. No.: HY-P99753
CAS No.: 162774-06-3
Synonyms: BAYX1351

Target:  

TNF Receptor

Research Areas:  

Infection

Nerelimomab (BAYX1351) is an anti-TNF-α antibody. Nerelimomab can be used for research of sepsis .
loading...
    loading...
Cat. No.: HY-161381
CAS No.: 3034837-89-0
PDE4-IN-15 (compound 7b-1) is an inhibitor of PDE4 (IC50 = 0.17 μM) and has anti-TNF-α activity (EC50 = 0.19 μM). PDE4-IN-15 has a good skin permeability .
loading...
    loading...
Cat. No.: HY-124388
CAS No.: 1396397-03-7
Research Areas:  

Inflammation/Immunology

PDE4-IN-20 is a selective submicromolar phosphodiesterase-4 (PDE4) inhibitor with anti-TNF-α properties. PDE4-IN-20 exhibits significant biological activity in vitro and in vivo. The mechanism of action of PDE4-IN-20 is supported by molecular modeling studies, which reveal its binding mode with PDE4. PDE4-IN-20 was optimized in further conformational analysis and showed pharmacological characteristics similar to those of known PDE4 inhibitors .
loading...
    loading...
Cat. No.: HY-126360R
CAS No.: 15646-46-5
Oxazolone (Standard) is the analytical standard of Oxazolone (HY-126360). This product is intended for research and analytical applications. Oxazolone is a haptenizing agent that induces acute or chronic inflammation of the large intestine and is used to construct models of colitis. Oxazolone can cause Th1/Th2-dependent colitis with weight loss and diarrhea. Oxazolone-induced inflammation can be mitigated by neutralizing anti-IL-4 or anti-TNF-α antibodies or decoy IL-13R2-α-FC proteins .
loading...
    loading...